AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects
Abstract Visceral obesity is characterized by a low-grade inflammatory systemic state that contributes to the genesis of non-alcoholic fatty liver disease (NAFLD), frequently associated with liver fibrosis. Non-invasive serum markers have recently emerged as reliable, easy-to-use scores to predict l...
Main Authors: | Carlo De Matteis, Marica Cariello, Giusi Graziano, Stefano Battaglia, Patrizia Suppressa, Giuseppina Piazzolla, Carlo Sabbà, Antonio Moschetta |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-94277-3 |
Similar Items
-
AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis
by: Aurora Loaeza-del-Castillo, et al.
Published: (2008-10-01) -
Use of AST platelet ratio index (APRI Score) as an alternative to liver biopsy for treatment indication in chronic hepatitis C
by: Mônica Salum Valverde Borsoi Viana, et al.
Published: (2009-01-01) -
APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level.
by: Yi-Hao Yen, et al.
Published: (2018-01-01) -
Gender, BMI and fasting hyperglycaemia influence Monocyte to-HDL ratio (MHR) index in metabolic subjects.
by: Stefano Battaglia, et al.
Published: (2020-01-01) -
Extra Virgin Olive Oil: Lesson from Nutrigenomics
by: Stefania De Santis, et al.
Published: (2019-09-01)